Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy

J Cardiometab Syndr. 2008 Spring;3(2):111-4. doi: 10.1111/j.1559-4572.2008.07552.x.

Authors

Zachariah Dorey-Stein¹, Valerianna K Amorosa, Jay R Kostman, Vincent Lo Re 3rd, Richard P Shannon

Affiliation

¹ Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

No abstract available

MeSH terms

Antiretroviral Therapy, Highly Active / adverse effects*
Dyslipidemias / chemically induced*
Dyslipidemias / epidemiology
HIV Infections / complications
HIV Infections / drug therapy*
Humans
Lipodystrophy / chemically induced*
Lipodystrophy / epidemiology
Sleep Apnea, Obstructive / chemically induced*
Sleep Apnea, Obstructive / epidemiology
Weight Gain / drug effects*

Grants and funding